We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

70 hedge funds and large institutions have $268M invested in Collegium Pharmaceutical in 2016 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 8

157% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 7

17% more funds holding

Funds holding: 60 → 70 (+10)

18% less capital invested

Capital invested by funds: $327M → $268M (-$58.3M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
70
Holders Change
+10
Holders Change %
+16.67%
% of All Funds
1.87%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
18
Increased
38
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EAM
Eventide Asset Management
Massachusetts
+$14.5M
2
Franklin Resources
Franklin Resources
California
+$9.19M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$5.65M
4
SAM
Sectoral Asset Management
Quebec, Canada
+$5.35M
5
HCMT
Highland Capital Management (Texas)
Texas
+$4.66M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$6.75M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.36M
3
Bank of America
Bank of America
North Carolina
-$1.11M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$358K
5
Renaissance Technologies
Renaissance Technologies
New York
-$328K
Name Holding Trade Value Shares
Change 		Change in
Stake
FM
1
Frazier Management
Washington
$34.3M +$182K +10,000 +0.5%
EAM
2
Eventide Asset Management
Massachusetts
$33.9M +$14.5M +798,878 +75%
TGHSA
3
TPG Group Holdings (SBS) Advisors
Texas
$24.1M – – –
HM
4
HealthCor Management
New York
$22.2M +$3.64M +200,000 +20%
RSCM
5
Rock Springs Capital Management
Maryland
$20.8M +$2.54M +139,513 +14%
Franklin Resources
6
Franklin Resources
California
$15.1M +$9.19M +505,299 +156%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$10.2M -$358K -19,700 -3%
BFA
8
BlackRock Fund Advisors
California
$9.13M +$1.54M +84,819 +20%
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$8.89M -$6.36M -350,000 -42%
RCM
10
RA Capital Management
Massachusetts
$8.83M -$6.75M -371,126 -43%
EC
11
EcoR1 Capital
California
$8.59M +$146K +8,005 +2%
CAM
12
Cormorant Asset Management
Massachusetts
$8.17M – – –
Vanguard Group
13
Vanguard Group
Pennsylvania
$8.15M +$3.64M +200,501 +81%
Massachusetts Financial Services
14
Massachusetts Financial Services
Massachusetts
$6.57M +$80.3K +4,420 +1%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$6.13M +$5.65M +310,731 +1,155%
SAM
16
Sectoral Asset Management
Quebec, Canada
$5.34M +$5.35M +294,400 New
HCMT
17
Highland Capital Management (Texas)
Texas
$4.65M +$4.66M +256,125 New
BIT
18
BlackRock Institutional Trust
California
$3.36M +$820K +45,120 +32%
AII
19
AGF Investments Inc
Ontario, Canada
$2.63M +$2.64M +145,000 New
TC
20
TFS Capital
Pennsylvania
$2.31M +$2.32M +127,568 New
EI
21
EAM Investors
California
$2.31M +$1.53M +84,171 +196%
State Street
22
State Street
Massachusetts
$2.01M +$631K +34,708 +46%
LPL Financial
23
LPL Financial
California
$1.97M +$1.01M +55,690 +106%
Northern Trust
24
Northern Trust
Illinois
$1.8M +$278K +15,267 +18%
SM
25
Sabby Management
Florida
$1.49M +$1.49M +82,100 New
1
2 3 4

COLL Hedge Fund Activity: Q1 2016 in Review

70 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q1 2016, worth a combined $268M — down 18% from $327M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new COLL positions and 7 closed out — a net gain of 11 holders — while 38 added to existing stakes and 8 trimmed.

The largest buyer was Eventide Asset Management, adding an estimated $14.5M. The largest seller was RA Capital Management, cutting an estimated $6.75M.

  • 70 institutional investors held Collegium Pharmaceutical (COLL) as of Q1 2016, up from 60 in Q4 2015.
  • Funds reported $268M of Collegium Pharmaceutical stock for Q1 2016, down 18% quarter-over-quarter.
  • 18 funds opened new Collegium Pharmaceutical positions in Q1 2016 and 7 closed out, a net change of +11 holders.
  • The largest Collegium Pharmaceutical buyer in Q1 2016 was Eventide Asset Management, an estimated $14.5M added.
  • The largest Collegium Pharmaceutical seller in Q1 2016 was RA Capital Management, an estimated $6.75M sold.

Based on aggregated 13F filings for Q1 2016.